PREDICTING PREECLAMPSIA IN EARLY PREGNANCY
PDF
DOI

Keywords

s-endoglin, placental growth factor (PlGF), prediction, TGF-β1

How to Cite

Kamilova Iroda Abdurasulovna, & Khalilova Shakhnoza Oybekovna. (2025). PREDICTING PREECLAMPSIA IN EARLY PREGNANCY. FRANCE - SCIENTIFIC REVIEW OF THE PROBLEMS AND PROSPECTS OF MODERN SCIENCE AND EDUCATION, 1(4), 23-26. https://e-conferences.org/index.php/france/article/view/250

Abstract

According to the World Health Organization (WHO), hypertensive disorders during pregnancy — including preeclampsia — are among the leading causes of maternal mortality and morbidity. Each year, approximately 500,000 women worldwide die from pregnancy- and childbirth-related complications, with 10–15% of these deaths attributed to hypertensive conditions, particularly preeclampsia and eclampsia. These conditions are more prevalent in low-income countries, where maternal mortality rates remain alarmingly high. For instance, maternal deaths due to preeclampsia and eclampsia are significantly more common in regions such as Africa and South Asia compared to other parts of the world. Preeclampsia affects approximately 2–8% of all pregnancies and poses serious risks not only to maternal health but also to fetal and neonatal outcomes

PDF
DOI